Trial Outcomes & Findings for Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants (NCT NCT01389882)
NCT ID: NCT01389882
Last Updated: 2012-01-09
Results Overview
peak inspiratory pressure measured by a ventilator for 4 hours with each ventilator mode
COMPLETED
PHASE2
26 participants
four hours
2012-01-09
Participant Flow
Participants recruited from a neonatal intensive care unit (NICU) of Seoul National University Hospital, in Seoul, Republic of Korea between March 2011 to July 2011.
26 patients enrolled; 24 assigned to randomization and 2 excluded (1 extubated prior to the study and 1 developed exclusion criteria)
Participant milestones
| Measure |
SN Group
Synchronized intermittent mandatory ventilation (SIMV) with Pressure support (PS) first, then Neurally adjusted ventilatory assist (NAVA)
|
NS Group
NAVA first, then SIMV with PS
|
|---|---|---|
|
Overall Study
STARTED
|
13
|
11
|
|
Overall Study
COMPLETED
|
12
|
7
|
|
Overall Study
NOT COMPLETED
|
1
|
4
|
Reasons for withdrawal
| Measure |
SN Group
Synchronized intermittent mandatory ventilation (SIMV) with Pressure support (PS) first, then Neurally adjusted ventilatory assist (NAVA)
|
NS Group
NAVA first, then SIMV with PS
|
|---|---|---|
|
Overall Study
Respiratory rate > 80/min during study
|
1
|
3
|
|
Overall Study
Withdrawal by Subject
|
0
|
1
|
Baseline Characteristics
Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants
Baseline characteristics by cohort
| Measure |
SN Group
n=13 Participants
Synchronized intermittent mandatory ventilation (SIMV) with Pressure support (PS) first, then Neurally adjusted ventilatory assist (NAVA)
|
NS Group
n=11 Participants
NAVA first, then SIMV with PS
|
Total
n=24 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age Continuous
|
7 days
n=5 Participants
|
5 days
n=7 Participants
|
5 days
n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
|
Region of Enrollment
Korea, Republic of
|
13 participants
n=5 Participants
|
11 participants
n=7 Participants
|
24 participants
n=5 Participants
|
|
Gestational Age
|
206 days
STANDARD_DEVIATION 28 • n=5 Participants
|
212 days
STANDARD_DEVIATION 20 • n=7 Participants
|
209 days
STANDARD_DEVIATION 24 • n=5 Participants
|
|
Birth Weight
|
990 g
n=5 Participants
|
1630 g
n=7 Participants
|
1075 g
n=5 Participants
|
|
Birth Height
|
37.2 cm
STANDARD_DEVIATION 5.9 • n=5 Participants
|
38.3 cm
STANDARD_DEVIATION 6.7 • n=7 Participants
|
37.7 cm
STANDARD_DEVIATION 6.2 • n=5 Participants
|
|
Study Day Postmenstrual Age
|
220 days
STANDARD_DEVIATION 20 • n=5 Participants
|
222 days
STANDARD_DEVIATION 15 • n=7 Participants
|
221 days
STANDARD_DEVIATION 18 • n=5 Participants
|
|
Study Day Body Weight
|
1210 g
n=5 Participants
|
1530 g
n=7 Participants
|
1355 g
n=5 Participants
|
|
Capillary Blood pH
|
7.31 pH
STANDARD_DEVIATION 0.04 • n=5 Participants
|
7.34 pH
STANDARD_DEVIATION 0.06 • n=7 Participants
|
7.32 pH
STANDARD_DEVIATION 0.05 • n=5 Participants
|
|
Capillary Blood pCO2
|
48.83 mmHg
STANDARD_DEVIATION 8.93 • n=5 Participants
|
44.45 mmHg
STANDARD_DEVIATION 6.34 • n=7 Participants
|
46.8 mmHg
STANDARD_DEVIATION 8.00 • n=5 Participants
|
|
Capillary Blood pO2
|
37.77 mmHg
STANDARD_DEVIATION 7.03 • n=5 Participants
|
37.00 mmHg
STANDARD_DEVIATION 8.80 • n=7 Participants
|
37.42 mmHg
STANDARD_DEVIATION 7.72 • n=5 Participants
|
|
Capillary Blood HCO3
|
24.20 mmol/L
STANDARD_DEVIATION 3.45 • n=5 Participants
|
21.62 mmol/L
STANDARD_DEVIATION 9.34 • n=7 Participants
|
23.02 mmol/L
STANDARD_DEVIATION 6.78 • n=5 Participants
|
PRIMARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
peak inspiratory pressure measured by a ventilator for 4 hours with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Peak Inspiratory Pressure
|
13.45 cmH2O
Standard Deviation 3.44
|
12.45 cmH2O
Standard Deviation 2.66
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
mean airway pressure measured by a ventilator for 4 hours with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Mean Airway Pressure
|
7.99 cmH2O
Standard Deviation 1.33
|
8.02 cmH2O
Standard Deviation 1.23
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Minute ventilation measured by a ventilator for 4 hours with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Minute Ventilation
|
0.53 L/min/Kg
Standard Deviation 0.15
|
0.51 L/min/Kg
Standard Deviation 0.11
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Expiratory tidal volume measured by a ventilator for 4 hours with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Expiratory Tidal Volume
|
8.73 mL/Kg
Standard Deviation 2.08
|
8.54 mL/Kg
Standard Deviation 2.24
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Dynamic Compliance measured by a ventilator for 4 hours with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Dynamic Compliance
|
1.70 mL/cmH2O
Standard Deviation 0.47
|
1.84 mL/cmH2O
Standard Deviation 0.36
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Work of breathing of patients measured by a ventilator for 4 hours with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Work of Breathing
|
11.13 mJ/L
Interval 3.92 to 60.79
|
8.38 mJ/L
Interval 1.6 to 30.21
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Peak electrical activity of the diaphragm
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Peak EAdi
|
13.39 uV
Standard Deviation 5.68
|
11.70 uV
Standard Deviation 5.72
|
SECONDARY outcome
Timeframe: four hoursFraction of oxygen measured by a ventilator for 4 hours with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Fraction of Oxygen
|
23.33 percentage of concentration
Interval 21.08 to 41.18
|
23.47 percentage of concentration
Interval 20.75 to 39.07
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Capillary blood pH checked immediately after the 4-hour respiratory support with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Capillary Blood pH
|
7.327 pH
Standard Deviation 0.051
|
7.334 pH
Standard Deviation 0.046
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Capillary blood pCO2 checked immediately after the 4-hour respiratory support with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Capillary Blood pCO2
|
46.75 mmHg
Standard Deviation 7.43
|
46.64 mmHg
Standard Deviation 7.87
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Capillary blood pO2 checked immediately after the 4-hour respiratory support with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Capillary Blood pO2
|
38.89 mmHg
Standard Deviation 8.82
|
37.84 mmHg
Standard Deviation 8.51
|
SECONDARY outcome
Timeframe: four hoursPopulation: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.
Capillary blood HCO3 checked immediately after the 4-hour respiratory support with each ventilator mode
Outcome measures
| Measure |
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
|
NAVA
n=19 Participants
neurally adjusted ventilatory assist
|
|---|---|---|
|
Capillary Blood HCO3
|
24.46 mmol/L
Standard Deviation 3.95
|
24.74 mmol/L
Standard Deviation 3.57
|
Adverse Events
SN Group
NS Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Juyoung Lee
Seoul National University Hospital
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place